A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

A U.S. judge ordered federal agencies to restore access to health-related webpages and datasets removed by the Trump ...

Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 ...

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Other experts agree. “When I’m helping patients find a plan for weight loss, I’m not saying, ‘Hey, let’s try this for 10 weeks and then switch,’” says Fatima Cody Stanford ...

Dr Craig Koniver, a family physician in Charleston, South Carolina, said he currently has 200 patients using the same method ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

On the charts, today's pop has NVO on track to snap a three-day losing streak. The stock still hasn't recovered from its ...